The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of of BCGP.
BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/
To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.
The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.
In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.
Target Audience: These recertification activities are intended for the Board-Certified Geriatric Pharmacist® (BCGP) and the Board-Certified Ambulatory Care Pharmacist® (BCACP) and those interested in strategies for implementing deprescribing in practice, treatments for osteoporosis and bone disorders in special populations, newer antidiabetic medications, and smoking cessation in older adults.
BCGP Clinical Session To D/C or Not to D/C — How to Implement Deprescribing into PracticeActivity Number: 0204-9999-24-250-H01-P Contact Hour(s): 1.00 Activity Type: Application Based Learning ObjectivesTo D/C or Not to D/C — How to Implement Deprescribing into Practice
- Describe the value of deprescribing within clinical practice.
- List key medication classes that should be considered for deprescribing.
- Develop a plan to optimize medication management through deprescribing based on a patient's goals of care and prognosis.
- Apply deprescribing communication techniques using the FRAME communication map.
|
BCACP/BCGP Clinical Session Bone Health Updates: “Breaking” Down Literature in Special Populations for Treatments of Osteoporosis and Other Bone DisordersActivity Number: 0204-9999-24-348-H01-P Contact Hour(s): 1.50 Activity Type: Application Based Learning ObjectivesBone Health Updates: "Breaking" Down Literature in Special Populations for Treatments of Osteoporosis and Other Bone Disorders
- Identify risk factors and treatment of osteoporosis, vitamin D deficiency, and other bone disorders.
- Interpret recent changes in safety, duration, and efficacy of selected therapy, including the removal of the boxed warning to PTH analogs.
- Assess treatment of osteoporosis and bone diseases in selected patient populations, including men, steroid-induced osteoporosis, pediatrics, and geriatrics.
- Develop a treatment plan for an individual with osteoporosis given patient-specific information.
|
BCACP/BCGP Clinical Session A New Day in Diabetes Control for the Older Adult? Using Newer Medications Across the Continuum of CareActivity Number: 0204-9999-24-324-H01-P Contact Hour(s): 1.50 Activity Type: Application Based Learning ObjectivesA New Day in Diabetes Control for the Older Adult? Using Newer Medications Across the Continuum of Care
- Evaluate the evidence base of newer diabetic agents in the older adult.
- Design a regimen for an older adult with diabetes considering goals and patient-related variables.
- Formulate a plan for addressing medication-related problems associated with the newer agents for diabetes in the older adult.
- Develop a transition plan for an older adult patient with diabetes from one care venue to another.
|
BCACP/BCGP Clinical Session Clearing the Clouds: Navigating Smoking Cessation in Older AdultsActivity Number: 0217-9999-24-065-H01-P Contact Hour(s): 1.00 Activity Type: Application Based Learning ObjectivesClearing the Clouds: Navigating Smoking Cessation in Older Adults
- Evaluate first-line pharmacotherapy options for treating older adults with tobacco dependence.
- Compare and contrast monotherapy versus combination pharmacotherapy for the treatment of older adults with tobacco dependence.
- Design an individualized smoking cessation treatment plan for an older adult patient.
- Evaluate obstacles encountered by older adults associated with tobacco cessation and recommend solutions.
- Summarize areas in which a clinical pharmacist can impact the care of older adults with tobacco dependence.
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.